Recruiting OBSERVATIONAL NCT05904301

Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases (NAREG)

Armenian Nationwide Registry of Systemic Autoimmune and Autoinflammatory Diseases

Sponsor: Santé Arménie French-Armenian Research Center

Conditions Antineutrophil Cytoplasmic Antibody (ANCA) Positive Vasculitis Behcet Disease Celiac Disease Giant Cell Arteritis Hereditary and Acquired Angioedema Primary Antiphospholipid Syndrome Rheumatoid Arthritis Sjogren's Syndrome Takayasu Arteritis

Interventions Usual medical management of patients, additional blood and stool samples for biobanking

Updated 4 times since 2023 Last updated: Apr 4, 2025 Started: Jun 21, 2023 Primary completion: Jun 30, 2028 Completion: Jun 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Antineutrophil Cytoplasmic Antibody (ANCA) Positive Vasculitis and Behcet Disease, this trial is actively recruiting participants. The trial is conducted by Santé Arménie French-Armenian Research Center and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

May 2025 — Present [monthly]

Recruiting
Sep 2024 — May 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jul 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Santé Arménie French-Armenian Research Center

Data source: Santé Arménie French-Armenian Research Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yerevan, Armenia